Prothiazine

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prothiazine

Property Description
Active ingredient Promethazine hydrochloride
Form Tablets, Syrup, Suppositories, Injection
Pharmacological class First-generation antihistamine, Phenothiazine derivative
Common use Allergy relief, Sedation, Anti-nausea/Antiemetic
Origin Synthetic

What Type of Medicine is Prothiazine?

Prothiazine is the trade name for a medication whose active ingredient is Promethazine hydrochloride, a potent synthetic compound fundamentally classified as a first-generation antihistamine.

This chemical substance is a phenothiazine derivative, distinguishing it from newer allergy medications, as its structure gives it powerful effects extending beyond simple histamine blockage. Promethazine is chemically defined by its phenothiazine core, which confers both its antihistaminic and central nervous system depressant properties. This confirms that the drug acts broadly on the central nervous system, which explains its calming effects. Unlike newer, non-sedating drugs, Promethazine acts as a general CNS depressant, which is a key distinguishing feature of this older class. While it is commonly prescribed as a single-ingredient product, its chemical structure and prescription-only (Rx) status define its controlled use.


Promethazine: Composition and Available Forms

The medication is composed of the Promethazine active ingredient, typically in its hydrochloride salt form, combined with specific excipients and an appropriate vehicle designed for stable delivery.

Due to the medication's functional versatility, it is supplied in multiple common dosage form(s). These include conventional tablets for oral use, a palatable syrup for liquid oral administration, suppositories for rectal administration when swallowing is difficult, and a sterile aqueous solution for injection (parenteral administration) in clinical settings. The availability of these distinct forms, especially the injection solution, ensures the drug can be administered effectively in situations like pre-operative sedation or acute episodes of vomiting.


What is the General Purpose of This Class of Drug?

The general purpose of a Promethazine-based medication is to provide relief for allergic symptoms and utilize its strong secondary effects for controlling sedation and nausea.

The principal action as a Histamine H1 receptor antagonist means it prevents the natural chemical histamine from triggering common acute allergy symptoms, such as itching, rhinorrhea, and watery eyes. Promethazine is clinically recognized for the active and prophylactic treatment of motion sickness and is useful as a sedative. This indicates the medication is verified for use in controlling nausea and helping to promote rest. Furthermore, the strong depressive and anticholinergic properties are utilized to promote general calmness and sedation, and to effectively suppress the brain signals responsible for feelings of nausea, vomiting, and motion sickness, making it a key antiemetic agent.

What side effects are possible with Prothiazine?

Possible Side Effects and Safety Information

The safety profile of Promethazine (Prothiazine) is primarily defined by effects on the central nervous system (CNS) and its anticholinergic activity, as documented in official regulatory labeling.

Adverse reactions are classified by the physiological system affected, consistent with standard regulatory frameworks.

Classification Description
Common Effects Sedation, drowsiness, dizziness, dry mouth, blurred vision, and constipation. These effects are often more pronounced at the initiation of treatment and may diminish with continued exposure.
System-Organ Classes Effects predominantly involve the Nervous System (e.g., sedation, dizziness), Gastrointestinal System (e.g., dry mouth), and Eye Disorders (e.g., blurred vision). Uncommon effects include photosensitivity and extrapyramidal symptoms.
Serious Adverse Reactions Documented serious risks include Neuroleptic Malignant Syndrome (NMS), rare but severe blood disorders like agranulocytosis, and the potential for severe tissue injury following inappropriate injection administration.

Population-Specific Safety Considerations

Official prescribing information includes critical restrictions for specific groups. Promethazine is contraindicated in pediatric patients younger than 2 years of age due to the potentially fatal risk of respiratory depression. In older adults, there is increased susceptibility to CNS depressant effects, confusion, and anticholinergic effects such as urinary retention. Furthermore, the drug is contraindicated in any patient exhibiting severe CNS depression or coma, and may impair the mental abilities required for operating machinery.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents state that immediate medical attention is required upon any suspicion of Prothiazine (Promethazine) overdose. It is necessary to contact emergency services or a poison control center right away for instruction, as mandated by regulatory authorities.

Overdose presentations are variable and population-specific. In adults, clinical manifestations often involve severe central nervous system (CNS) depression, characterized by profound drowsiness and potential progression to coma. In contrast, pediatric patients may experience CNS excitation, including agitation, hallucinations, seizures, ataxia, and incoordination. Additional documented signs include dilated pupils and dry mouth.

Regulators document several severe, potentially life-threatening outcomes. These include fatal respiratory depression, apnea, severe hypotension, and cardiac rhythm irregularities. Specific warnings exist regarding the potential for Neuroleptic Malignant Syndrome (NMS) and the risk of sudden death following excessive dosages in children.

Management is defined as strictly symptomatic and supportive, as no specific antidote is known. Required procedures include continuous medical monitoring of vital signs and ECG tracing. Official prescribing information explicitly warns against the use of Epinephrine to treat overdose-associated low blood pressure.

Therapeutic Uses of Prothiazine

What Prothiazine Treats: Main Uses and Benefits

Prothiazine (Promethazine) is commonly used across conditions presenting with acute or disruptive episodes, and is relevant when supportive symptom management is appropriate. Promethazine's therapeutic applications are focused on several key symptomatic domains.

This medication is applied in addressing certain distressing symptoms of allergic reactions, including hay fever, allergic conjunctivitis, and uncomplicated urticaria. It is also commonly used to manage nausea, active vomiting, and motion sickness, as well as to help promote quiet sleep and manage apprehension in contexts like pre-operative settings.

The medication helps address symptom clusters that may become intense or disruptive, such as persistent itching, sneezing, and excessive runny nose, which contributes to easing the overall symptom load. For patients experiencing acute distress, the benefit may be associated with its calming effect.

“This supportive relief helps patients cope more steadily with symptom fluctuations and supports general well-being.”


Use Focus: Nausea and Restlessness

Prothiazine is often used during phases when symptoms become more noticeable, such as post-operatively, to help manage distress and encourage rest. This action assists with maintaining functional stability during difficult episodes.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Prothiazine (Promethazine) eligibility is strictly defined by regulatory documents, focusing on patient status, age, and pre-existing conditions.

Absolute Prohibitions (Contraindications)

The medicine is strictly contraindicated for children under two years of age due to the risk of potentially fatal respiratory depression. It must not be used in individuals in a comatose state or those with a confirmed hypersensitivity to promethazine or related phenothiazine compounds. The drug is also prohibited for treating lower respiratory tract symptoms, including asthma, and specific injection routes (subcutaneous or intra-arterial) are prohibited.

Conditional and Restricted Use

Use in pediatric patients aged two years and older requires the lowest effective dose and caution. Older adults may also require dosage reduction due to increased sensitivity to the drug's effects. The medicine is not recommended for use in nursing mothers or during the last two weeks of pregnancy.

Patients with underlying conditions such as renal dysfunction, impaired liver function, narrow-angle glaucoma, prostatic hypertrophy, or seizure disorders must use the medicine with caution, as these conditions affect eligibility and are noted in official labeling. Use should also be avoided in acutely ill or dehydrated pediatric patients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Promethazine (Prothiazine) has officially documented interaction patterns primarily centered on its strong Central Nervous System (CNS) depressant and anticholinergic properties, as noted in regulatory prescribing information.

Pharmacodynamic Interactions

Co-administration with other CNS depressants (including sedatives, narcotics, and tricyclic antidepressants) may increase, prolong, or intensify the sedative action. The use of Alcohol is a contraindicated combination due to the amplification of CNS depressant effects. Similarly, concurrent use of other anticholinergic agents enhances the additive anticholinergic action. Promethazine may also decrease the vasopressor effect of Epinephrine.

Interaction-Related Restrictions and Timing Rules

Specific restrictions are tied to concomitant use. Monoamine Oxidase Inhibitors (MAOIs) are avoided for up to 14 days following their discontinuation. For diagnostic procedures, Promethazine must be discontinued at least 72 hours prior to allergen skin testing to prevent false-negative results. While Promethazine is noted as a moderate inhibitor of CYP2D6, the major warnings relate to its pharmacodynamic potentiation. Dosage adjustments may be necessary for concurrent antihypertensive therapy in the elderly to manage the risk of hypotension.

Mechanism of Action

Pharmacodynamic Mechanism of Prothiazine

Prothiazine acts as a non-competitive antagonist at several critical neuroreceptor sites. Its primary mechanism involves high-affinity blockade of central and peripheral Histamine H1 receptors. This action interrupts the H1-mediated signaling cascade, suppressing processes such as localized vasodilation and afferent nerve fiber activation. The drug readily crosses the blood-brain barrier, resulting in pronounced central nervous system depression.

Simultaneously, Prothiazine functions as an antagonist at muscarinic acetylcholine receptors and D2 dopamine receptors. In the brainstem, this multi-receptor interference modulates key signaling patterns, specifically disrupting afferent and efferent neural pathways within the medullary vomiting center. Furthermore, antagonism at alpha1-adrenergic receptors and muscarinic receptors contributes to the suppression of parasympathetic signals and generalized reduction in glandular secretions.

Dosage and Administration Information

How Prothiazine is Used: Official Administration Guidelines

Prothiazine (Promethazine) is used according to strict guidelines concerning the route, dosage, frequency, and preparation of the medicine. These instructions standardize its application across different clinical scenarios.


Approved Administration Routes and Forms

Promethazine is available and approved for administration via multiple routes. These include oral use (tablets and syrup), rectal use (suppositories), and parenteral use as an injection. The preferred injectable route is deep Intramuscular (IM) injection; intravenous (IV) use is allowed only under specific procedural conditions to minimize risk.

Standard Dosing and Frequency

Official dosing is based on the condition being addressed, using the lowest effective amount. The standard dose for treating allergic conditions is typically 25 mg taken once daily at bedtime, or 6.25 mg to 12.5 mg taken before meals and at bedtime. For the treatment of nausea and vomiting, the dose is typically 12.5 mg to 25 mg, repeated every 4 to 6 hours as needed.

Administration Requirements

Instruction Type Official Requirement
Oral Intake Can be taken with food, water, or milk to help reduce potential stomach irritation.
IV Preparation Must be diluted prior to use and administered through a large vein (not hand or wrist veins).
IV Rate Limit Infusion must not exceed a rate of 25 mg / minute.
Pediatric Rule Use is contraindicated in children under 2 years old.

When Prothiazine is administered for sedation alongside other central nervous system depressants, the dose of the other agent (e.g., narcotics) must be reduced.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Promethazine

Evidence for Use in Managing Nausea and Vomiting

Research has studied Promethazine for outcomes related to systemic or functional imbalance, primarily focusing on controlling sickness and vomiting. The evidence includes Randomized Controlled Trials (RCTs) examining how symptoms evolved in adult patients during acute episodes, such as immediate recovery after surgery. Findings describe patterns observed in the studies where measurements of nausea and vomiting were observed to change in the short-term. The evidence contributes to understanding episodic or acute changes, but follow-up durations are typically limited to a few hours or days.

Evidence for Use in Acute Sedation and Calming Apprehension

Promethazine was evaluated in studies exploring its role in promoting rest and addressing apprehension. Research examined its use in adults who were included during surgical preparation and children over two years for procedural support. Findings described patterns observed in the studies where medication contributed to a state of calmness and light sleep. Evidence remains limited regarding how the outcomes compare to other specialized sedatives, particularly in non-acute settings.

Evidence for Use in Symptomatic Allergy Relief

The evidence for this use is based on its classification as a first-generation antihistamine, with foundational trials exploring its role in conditions involving periods of heightened symptoms like hay fever. These studies data show patterns related to the drug's role in the body's histamine response, and outcomes describing episodic or acute changes in symptoms was observed in some studies. Comparative evidence is lacking against newer non-sedating antihistamines for chronic management.

Long-Term Studies and Follow-Up Duration

Research is largely concentrated on research exploring short-term symptom changes during acute events. Because of this focus, follow-up durations were limited (hours to days). Consequently, long-term outcomes are not fully established in the research literature, and the focus is on acute relief, not maintenance.

Evidence in Special Populations

Studies was evaluated in specific cohorts of children over two years of age for procedural sedation, and adults in acute settings like labor. However, data for certain groups remain insufficient. For instance, there is limited information on outcomes for older adults or patients with comorbidities. Research provides context but not individual predictions for these specific groups.

What is Still Uncertain About Promethazine Research

Research highlights areas where certainty remains low. Primary research limitation frames include the fact that comparative evidence is lacking against modern alternatives in some of its uses. The sample sizes were modest in some specialized studies, and evidence quality varies across studies due to the age of the drug.

Key Studies & References

  1. Promethazine - StatPearls - NCBI Bookshelf - NIH (Supporting indications, first-generation classification, and acute use context)

Frequently Asked Questions (FAQ)

Common questions about Prothiazine (FAQ)


Q: Is Prothiazine the same as promethazine?

Prothiazine is a recognized trade name for this medication. The active ingredient within Prothiazine is Promethazine hydrochloride. This indicates that Prothiazine and Promethazine refer to the same therapeutic compound.


Q: How long does it take for Prothiazine to start working for sleep?

According to official product information, the clinical effects of the medicine usually begin to appear within 20 minutes after taking it by mouth. The primary sedative effect is related to this onset of action.


Q: How long does the effect of Prothiazine last?

The effects of the medication generally last between four to six hours. However, regulatory documents indicate that the sedative effects can persist for up to 12 hours.


Q: Can Prothiazine affect blood pressure readings?

Yes, official labeling notes that the medicine may cause adverse effects on the cardiovascular system, including changes in blood pressure, specifically both increases and decreases. It may also affect heart rate, potentially leading to a fast heart rate (tachycardia) or a slow heart rate (bradycardia).


Q: Is Prothiazine habit-forming or addictive?

Official prescribing information for Promethazine alone does not carry warnings regarding abuse or addiction risk. However, formulations where Promethazine is combined with an opioid, such as Codeine, carry specific warnings regarding the potential for addiction, abuse, and misuse due to the presence of the opioid component.


Q: Is Prothiazine a controlled substance?

Promethazine by itself is not classified as a controlled substance by the FDA. However, products where Promethazine is compounded with the opioid Codeine are generally classified as a Schedule C-V controlled substance.


Q: What should I do if I miss a dose of Prothiazine?

Regulatory patient information describes the protocol for a missed dose intended for motion sickness as being taken as soon as it is remembered. For all other conditions, the official guidance is generally to skip the missed dose and resume the regular dosing schedule at the usual time.


Q: Is it common to feel groggy the morning after taking Prothiazine?

Drowsiness and sedation are the most prominent central nervous system effects of this drug. Since the effects can persist for up to 12 hours, a residual sedative effect the following morning may occur.


Q: Can Prothiazine affect my driving ability?

Regulatory warnings state that Promethazine may impair the mental and physical abilities required to perform potentially hazardous tasks. This includes tasks such as driving a vehicle or operating machinery.


Q: Does Prothiazine change the way my liver works?

The official labeling notes that Promethazine is metabolized, or processed, by the liver into various compounds. Caution is advised when the medicine is used in individuals with pre-existing impaired liver function. Additionally, jaundice has been reported as an adverse reaction in some cases.


Q: Does Prothiazine show up on standard drug tests?

The active ingredient, Promethazine, is not typically included in standard drug test panels as it is not classified as a controlled substance alone. However, based on its chemical structure, there are limited reports suggesting it may cause a false positive result for amphetamines on some screens.


Q: What kind of research has been done on Prothiazine use in pregnancy?

The official labeling states that it is not known whether the medicine can cause fetal harm when administered during pregnancy. Regulatory documents include restrictions on use during the last two weeks of pregnancy. For codeine-containing Promethazine products, prolonged use during pregnancy may result in neonatal opioid withdrawal syndrome.


Q: Is Prothiazine available without a prescription?

No, Promethazine is classified by regulatory bodies as a prescription-only (Rx) medication. It is not available for purchase over the counter.


Q: Why do people sometimes feel anxious after taking Prothiazine?

Official labeling reports the possibility of 'paradoxical reactions,' which are reactions opposite to the expected sedative effect. These reactions may include hyperexcitability, nervousness, or agitated behavior.


Q: Can Prothiazine cause hallucinations?

Yes, the potential for hallucinations has been documented in regulatory sources. This is noted as a possible adverse reaction involving the central nervous system.


Q: Can Prothiazine cause changes in heart rhythm?

Official labeling notes that adverse effects on the cardiovascular system are possible. These may include changes in heart rate, such as tachycardia (a fast heart rate) or bradycardia (a slow heart rate).


Q: Does Prothiazine cause vivid dreams or nightmares?

Regulatory information documents that nightmares have been reported as a possible adverse reaction. This effect is noted as part of the category of paradoxical or unexpected reactions to the medication.


Q: Can Prothiazine be used for allergies that cause hives?

Yes, regulatory documents state the medicine is officially indicated for the treatment of mild, uncomplicated allergic skin manifestations. This specifically includes hives (urticaria) and angioedema.


Q: What are the contraindications listed for Prothiazine?

The official contraindications specify that the medicine must not be used in children under 2 years old, patients in a comatose state, or individuals with a known hypersensitivity to Promethazine. It is also prohibited for treating lower respiratory tract symptoms, including asthma.

How should Prothiazine be stored and disposed of?

How to Store and Dispose of Prothiazine?

The official storage requirements for Promethazine are defined by the dosage form and stability profile. Tablets, Syrup, and Injection must be kept at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), while Suppositories strictly require refrigeration (2 C to 8 C).

All forms must be protected from light and kept from freezing. Liquid and injection solutions require visual inspection; they should not be used if discoloration or precipitation is observed, as this indicates instability.

Mandatorily, the medication must be stored out of the sight and reach of children.

For disposal, the product is not on the FDA flush list and should not enter the wastewater system. Unused or expired medication should be discarded using a drug take-back program or through recommended proper household disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prothiazine found in:

A-Z Index: